Compare · CVII vs MACA
CVII vs MACA
Side-by-side comparison of Churchill Capital Corp VII (CVII) and Moringa Acquisition Corp (MACA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CVII and MACA operate in Blank Checks (Finance), so they compete in similar markets.
- CVII is the larger of the two at $1.68B, about 11.7x MACA ($143.8M).
Churchill Capital Corp VII
Churchill Capital Corp VII focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
Moringa Acquisition Corp
Moringa Acquisition Corp does not have significant operations. The company intends to acquire assets and businesses through a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It focuses on pursuing opportunities in technology-based businesses or industries in Israel. The company was incorporated in 2020 and is based in New York, New York.
Latest CVII
- Amendment: SEC Form SC 13G/A filed by Churchill Capital Corp VII
- SEC Form 15-12G filed by Churchill Capital Corp VII
- Large owner Magnetar Financial Llc disposed of $90,084,438 worth of shares (8,306,005 units at $10.85) (SEC Form 4)
- Churchill Capital Corp VII filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Churchill Capital Corp VII
- Churchill Capital Corp VII and CorpAcq Mutually Agree to Terminate Business Combination
- SEC Form 10-Q filed by Churchill Capital Corp VII
- Churchill Capital Corp VII filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form DEFA14A filed by Churchill Capital Corp VII
- SEC Form DEFA14A filed by Churchill Capital Corp VII
Latest MACA
- PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers
- Amendment: SEC Form SCHEDULE 13G/A filed by Moringa Acquisition Corp
- SEC Form 15-12G filed by Moringa Acquisition Corp
- Moringa Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Moringa Acquisition Corp
- Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination
- SEC Form 10-Q filed by Moringa Acquisition Corp
- Moringa Acquisition Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form DEFM14A filed by Moringa Acquisition Corp
- Moringa Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits